Skip to content

Feasibility Trial for Detecting Drug-induced Respiratory Depression and Prompting for Self-rescue

Feasibility Trial for Detecting Drug-induced Respiratory Depression and Prompting for Self-rescue

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02744599
Enrollment
26
Registered
2016-04-20
Start date
2013-10-31
Completion date
2015-03-31
Last updated
2019-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Feasibility trial

Brief summary

This is a small trial to test feasibility of an idea for a potential device. The investigators tested the feasibility of prompting a volunteer to breathe when their breathing had slowed down during administration of anesthetic drugs.

Interventions

DEVICEPrompting breaths via recorded voice, vibrating massager, and/or muscle tetany

Prompt volunteer to breathe using device to play recorded voice, massage the body, and/or apply muscle tetany

Sponsors

National Institute of Nursing Research (NINR)
CollaboratorNIH
University of Utah
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* American Society of Anesthesia (ASA) Class I and Class II male and female (non-pregnant/non-lactating) volunteers. * Normal healthy individual as indicated by medical history and a physical examination. * At least 18 years of age and less than 55 years of age. * Negative drug screen. * Uncomplicated airway anatomy. * A Body Mass Index between 18 and 32. * Are fully informed of the risks of entering the study and willingly provide written consent to enter the trial. * Female subjects of child bearing potential will have a negative urine pregnancy test on the day the study is conducted.

Exclusion criteria

* Known or suspected neurological pathologies. * A history of significant alcohol or drug abuse, a history of allergy to opioids or propofol, or a history of chronic drug requirement or medical illness that is known to alter the pharmacokinetics or pharmacodynamics of remifentanil and propofol. * Known obstructive sleep apnea. * Known or suspected hypersensitivity to any compound present in the study. * Any potential subject suffering from medical problems that, in the judgment of the investigator, presents unacceptable risk to the volunteer are not eligible for enrollment. * Vulnerable subject groups such as prisoners and the mentally disabled that are traditionally excluded from medical research are also excluded. * The potential subject has taken any medication within 2 days prior to chosen drug administration, with the exception of oral contraceptives. * The potential subject is wearing artificial nails. * A positive urine pregnancy test (females only) * Female subjects who are currently lactating & breast-feeding. * A positive drug-screening test. * The subject consumed food or fluids within 8 hours prior to start of each chosen drug administration. * Any medications or alcohol within 2 days prior to start of the chosen drug administration, with the exception of oral contraceptives.

Design outcomes

Primary

MeasureTime frame
Breath prompting successful rateChange in respiratory rate from baseline to the period 10 seconds after the breath prompt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026